Midterm outcomes of fenestrated TEVAR using physician-modified endovascular grafts for zone 2

Abstract

Objectives

To summarize the experience and midterm outcomes of physician-modified endovascular grafts for zone 2 thoracic endovascular aortic repair.

Methods

A retrospective analysis was conducted of 51 consecutive patients (mean age 57.6 ± 12.5 years, 39 males) treated with thoracic endovascular aortic repair using physician-modified endovascular grafts for reconstructing the left subclavian artery from November 2015 to December 2019. The primary endpoints during follow-up were the overall mortality, aorta-related mortality, and major complications. The secondary endpoints were reintervention and the patency of the target branches, the demographics and technical details were also described and analyzed.

Results

Sixty-three thoracic stent-grafts were deployed in 51 patients and emergency surgery was performed in 10 patients (19.6%). Technical success was 94.1% (48/51). The incidence of perioperative complications was 15.7%, and the 30-day mortality was 0%. At a mean follow-up of 42.0 ± 14.4 months (range, 14–63 months), all the left subclavian arteries remained patent. All-cause mortality was 3.9% (2/51) and not aorta-related deaths. Estimated survival at one and three years was 98.0 ± 1.9% and 96.0 ± 2.8%, respectively.

Conclusions

The physician-modified endovascular grafts is feasible and effective to preserve left subclavian artery in thoracic endovascular aortic repair for aortic arch pathologies with unhealthy proximal landing zone.

Keywords

Aortic pathology thoracic endovascular aortic repair left subclavian artery fenestration physician-modified endovascular grafts

Get full access to this article

View all access options for this article.

References

Yuan

Mitsis

Tang

, et al.

The IRAD and beyond: what have we unravelled so far?

Gen Thorac Cardiovasc Surg 2019; 67: 146–153.

Riambau

Böckler

Brunkwall

, et al. Management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2017; 53: 4–52.

Waterford

Chou

Bombien

, et al. Left subclavian arterial coverage and stroke during thoracic aortic endografting: a systematic review. Ann Thorac Surg 2016; 101: 381–389.

Wilson

Galiñanes

, et al. Routine revascularization is unnecessary in the majority of patients requiring zone II coverage during thoracic endovascular aortic repair: a longitudinal outcomes study using United States Medicare population data. Vascular 2014; 22: 239–245.

Weigang

Parker

Czerny

, et al.

Should intentional endovascular stent-graft coverage of the left subclavian artery be preceded by prophylactic revascularisation?

Eur J Cardiothorac Surg 2011; 40: 858–868.

Matsumura

Lee

Mitchell

, et al. The Society for Vascular Surgery Practice Guidelines: management of the left subclavian artery with thoracic endovascular aortic repair. J Vasc Surg 2009; 50: 1155–1158.

Canonge

Jayet

Heim

, et al. Comprehensive review of physician modified aortic stent grafts: technical and clinical outcomes. Eur J Vasc Endovasc Surg 2021. DOI: 10.1016/j.ejvs.2021.01.019.

Chassin-Trubert

Mandelli

Ozdemir

, et al. Midterm follow-up of fenestrated and scalloped physician-modified endovascular grafts for Zone 2 TEVAR. J Endovasc Ther 2020; 27: 377–384.

Geisbüsch

Kotelis

Müller-Eschner

, et al. Complications after aortic arch hybrid repair. J Vasc Surg 2011; 53: 935–941.

10.

Bünger

Kische

Liebold

, et al. Hybrid aortic arch repair for complicated type B aortic dissection. J Vasc Surg 2013; 58: 1490–1496.

11.

Wang

Shu

, et al. Thoracic endovascular aortic repair with single/double chimney technique for aortic arch pathologies. J Endovasc Ther 2017; 24: 383–393.

12.

Crawford

Sanford

Forbes

, et al. Clinical outcomes and material properties of in situ fenestration of endovascular stent grafts. J Vasc Surg 2016; 64: 244–250.

13.

Canaud

Ozdemir

Chassin-Trubert

, et al. Homemade fenestrated stent-grafts for complete endovascular repair of aortic arch dissections. J Endovasc Ther 2019; 26: 645–651.

14.

Joseph

Premkumar

Thomson

, et al. Externalized guidewires to facilitate fenestrated endograft deployment in the aortic arch. J Endovasc Ther 2016; 23: 160–171.

15.

Canaud

Baba

Gandet

, et al. Physician-modified thoracic stent-grafts for the treatment of aortic arch lesions. J Endovasc Ther 2017; 24: 542–548.

16.

Zhu

Zhao

Dai

, et al. Fenestrated thoracic endovascular aortic repair using physician modified stent grafts for acute type B aortic dissection with unfavourable landing zone. Eur J Vasc Endovasc Surg 2018; 55: 170–176.

17.

Canaud

Ozdemir

Chassin-Trubert

, et al. Double homemade fenestrated stent graft for total endovascular aortic arch repair. J Vasc Surg 2019; 70: 1031–1038.

18.

Huang

Hsu

Chen

, et al. The impact of distal stent graft-induced new entry on aortic remodeling of chronic type B dissection. Ann Thorac Surg 2018; 105: 785–793.

19.

Jang

Kim

, et al. Risk factors for stent graft-induced new entry after thoracic endovascular aortic repair for Stanford type B aortic dissection. J Vasc Surg 2017; 65: 676–685.

20.

Zhu

Huang

Zhao

, et al. Influence of distal entry tears in acute type B aortic dissection after thoracic endovascular aortic repair. J Vasc Surg 2017; 66: 375–385.

21.

Miura

Kurimoto

Maruyama

, et al. Thoracic endovascular aortic repair on Zone 2 landing for type B aortic dissection. Ann Vasc Surg 2019; 60: 120–127.

22.

Feng

Zhao

, et al. Restrictive bare stent for prevention of stent graft-induced distal redissection after thoracic endovascular aortic repair for type B aortic dissection. J Vasc Surg 2013; 57: 44s–52s.

23.

Wang

, et al. Risk factors for distal stent graft-induced new entry following endovascular repair of type B aortic dissection. J Thorac Dis 2015; 7: 1907–1916.